SEC Filing Details

Document Details

Filing Date
Apr 10, 2019
Document Date
Apr 10, 2019
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
Outlook Therapeutics, Inc.
Issuer
Oncobiologics, Inc.